Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
AnagenX is different
Our specialists empower patients with evidence-based strategies to engage in their overall health and achieve personal wellness goals
Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma
Menses AG, Ferreira EB, Vieira LAC, Bontempo P, de SM, Guerra ENS, Ciol MA, et al
It is currently in late-stage clinical trials (phase 3) and has not received a marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)
Toxicology Letters , 258 , 168174
US$ 26.63
US$ 27.43
US$ 27.77
US$ 23.98
